Re: Efficacy of Everolimus in Advanced Renal Cell Carcinoma: A Double-Blind, Randomised, Placebo-Controlled Phase III Trial

被引：1
|
作者：
Pouliot, Frederic [1 ]
Pantuck, Allan J. [1 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USA
来源：
EUROPEAN UROLOGY | 2009年 / 55卷 / 06期
关键词：
D O I：
10.1016/j.eururo.2009.03.034
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1482 / 1484
页数：3
相关论文
共 50 条
  • [1] Efficacy of everolimus in advanced renal cell carcinoma:: a double-blind, randomised, placebo-controlled phase III trial
    Motzer, Robert J.
    Escudier, Bernard
    Oudard, Stephane
    Hutson, Thomas E.
    Porta, Camillo
    Bracarda, Sergio
    Gruenwald, Viktor
    Thompson, John A.
    Figlin, Robert A.
    Hollaender, Norbert
    Urbanowitz, Gladys
    Berg, William J.
    Kay, Andrea
    Lebwohl, David
    Ravaud, Alain
    LANCET, 2008, 372 (9637): : 449 - 456
  • [2] Re: Efficacy of Everolimus in Advanced Renal Cell Carcinoma: A Double-Blind, Randomized, Placebo-Controlled Phase III Trial
    Culp, Stephen H.
    Wood, Christopher G.
    EUROPEAN UROLOGY, 2009, 55 (06) : 1484 - 1485
  • [3] Adjuvant everolimus after surgery for renal cell carcinoma (EVEREST): a double-blind, placebo-controlled, randomised, phase 3 trial
    Ryan, Christopher W.
    Tangen, Catherine M.
    Heath, Elisabeth, I
    Stein, Mark N.
    Meng, Maxwell, V
    Alva, Ajjai S.
    Pal, Sumanta K.
    Puzanov, Igor
    Clark, Joseph, I
    Choueiri, Toni K.
    Agarwal, Neeraj
    Uzzo, Robert G.
    Haas, Naomi B.
    Synold, Timothy W.
    Plets, Melissa
    Vaishampayan, Ulka N.
    Shuch, Brian M.
    Thompson Jr, Ian M.
    Lara Jr, Primo N.
    LANCET, 2023, 402 (10407): : 1043 - 1051
  • [4] Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
    Cheng, Ann-Lii
    Kang, Yoon-Koo
    Chen, Zhendong
    Tsao, Chao-Jung
    Qin, Shukui
    Kim, Jun Suk
    Luo, Rongcheng
    Feng, Jifeng
    Ye, Shenglong
    Yang, Tsai-Sheng
    Xu, Jianming
    Sun, Yan
    Liang, Houjie
    Liu, Jiwei
    Wang, Jiejun
    Tak, Won Young
    Pan, Hongming
    Burock, Karin
    Zou, Jessie
    Voliotis, Dimitris
    Guan, Zhongzhen
    LANCET ONCOLOGY, 2009, 10 (01): : 25 - 34
  • [5] Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial
    Cid, Maria C.
    Unizony, Sebastian H.
    Blockmans, Daniel
    Brouwer, Elisabeth
    Dagna, Lorenzo
    Dasgupta, Bhaskar
    Hellmich, Bernhard
    Molloy, Eamonn
    Salvarani, Carlo
    Trapnell, Bruce C.
    Warrington, Kenneth J.
    Wicks, Ian
    Samant, Manoj
    Zhou, Teresa
    Pupim, Lara
    Paolini, John F.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (05) : 653 - 661
  • [6] A randomised, double-blind, placebo-controlled phase III trial on the efficacy and safety of tocilizumab in patients with familial Mediterranean fever
    Koga, T.
    Sato, S.
    Hagimori, N.
    Yamamoto, H.
    Ishimura, M.
    Yasumi, T.
    Kirino, Y.
    Ikeda, K.
    Yachie, A.
    Migita, K.
    Kishida, D.
    Atsumi, T.
    Kawakami, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (08) : 1535 - 1542
  • [7] Efficacy and safety of mepolizumab in a Chinese population with severe asthma: a phase III, randomised, double-blind, placebo-controlled trial
    Chen, Ruchong
    Wei, Liping
    Dai, Yuanrong
    Wang, Zaiyi
    Yang, Danrong
    Jin, Meiling
    Xiong, Cui
    Li, Ting
    Hu, Shuling
    Song, Jie
    Chan, Robert
    Kumar, Subramanya
    Abdelkarim, Azza
    Zhong, Nanshan
    ERJ OPEN RESEARCH, 2024, 10 (03)
  • [8] Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial
    Kordes, Sil
    Pollak, Michael N.
    Zwinderman, Aeilko H.
    Mathot, Ron A.
    Weterman, Mariette J.
    Beeker, Aart
    Punt, Cornelis J.
    Richel, Dick J.
    Wilmink, Johanna W.
    LANCET ONCOLOGY, 2015, 16 (07): : 839 - 847
  • [9] Efficacy and Safety of Tofacitinib in Ankylosing Spondylitis: A Randomised, Double-blind, Placebo-controlled Trial
    Harish, B., V
    Sahoo, Rasmi Ranjan
    Gochhait, Samanyoya
    Patro, Pradeepta Sekhar
    INDIAN JOURNAL OF RHEUMATOLOGY, 2025, 20 (01) : 27 - 34
  • [10] SEARCH: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Sorafenib Plus Erlotinib in Patients With Advanced Hepatocellular Carcinoma
    Zhu, Andrew X.
    Rosmorduc, Olivier
    Evans, T. R. Jeffry
    Ross, Paul J.
    Santoro, Armando
    Carrilho, Flair Jose
    Bruix, Jordi
    Qin, Shukui
    Thuluvath, Paul J.
    Llovet, Josep M.
    Leberre, Marie-Aude
    Jensen, Markus
    Meinhardt, Gerold
    Kang, Yoon-Koo
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (06) : 559 - 566
12345